Gbenga (pronounced as: Benga) is a proficient statistical scientist who has an extensive practical experience in applying various statistical methodologies to biomedical research studies. He is an oxbridge graduate – he received his master’s degree (MPhil) in statistical science from the University of Cambridge and his doctorate degree (DPhil) in applied statistics (statistical genetics) from the University of Oxford. Whilst at Oxford, his research work focused on the development and applications of statistical methods for genetic association studies. These are studies that aim to identify common genetic variations in human genome that predispose to the development of common diseases.
Following the completion of his PhD studies at Oxford in 2005, he worked briefly as a Research Associate at the University of Birmingham (Department of Public Health and Epidemiology) before moving into the pharmaceutical industry in 2006 when he joined GlaxoSmithKline (GSK), a global pharmaceutical company, where he worked as a Senior Statistical Scientist and later as Principal Statistical Scientist until 2010. He established BENKAZ Consulting Ltd in 2010 and since then he has worked with the company Consulting Biostatistician providing expert statistical advice, strategic input and support for the design, analyses and reporting of clinical trials (both in early and late phase), non-interventional (observational) studies and genomics biomarkers studies for drug development and commercialization.
He has over 15 years of experience of working both in academia and industry. He has worked on wide range of projects in clinical drug discovery, development and commercialization within different therapy areas (including oncology, neuroscience, immunology, infectious diseases and respiratory) with a number of large pharmaceuticals (GSK, Eli Lilly, Astellas, Daiichi-Sankyo) and biotechnology companies. He has authored and co-authored many published scientific articles in peer-reviewed journals.